The global Brachytherapy market gathered revenue around USD 789.2 Million in 2020 and market is set to grow USD 106.2 Million by the end of 2027 and is estimated to expand at a modest CAGR of 9.20% during the prediction period 2021 to 2027. The increasing prevalence of cancer, technological advancements, and a significant rise in the adoption of brachytherapy are expected to drive the growth of the market during the forecast period. Brachytherapy is a type of radiation therapy used for the treatment of cancer. The radioactive materials are placed inside the body with the help of catheters.
Moreover, government hospitals in developing countries are installing advanced systems to provide better quality treatment for their patients. For instance, in August 2019, Eckert and Ziegler BEBIG delivered and installed SagiNova HDR afterloader at BP Koirala Memorial Cancer Hospital of Nepal. SagiNova is suitable for interstitial breast implants. Hence, the use of such brachytherapy systems by hospitals is expected to fuel market growth.
The new study made on Brachytherapy market includes crucial information on market share, market size, and growth rate for the forecast period 2021 to 2027. The study highlights deep analysis on the major drivers of the market, restraints, and challenges to help the business owners, suppliers, and marketing personnel in planning effective strategies for the forecast period. This will help the business and manufacturers to lead the market and gain prominent position in future. The report also presents vital information through graphical representation on factors like table, charts, and statistics.
COVID-19 Impact:
The industrial report mentions about the influence of the ongoing COVID-19 pandemic. The outbreak has caused disturbances in several industries and has hammered the logistics, resulting in delayed deliveries and cancellation of product demand. The Brachytherapy report proficiently explains about the resulting factors and concerns of manufacturers. Researchers have also well-explained about how the producers and providers will tackle with the ongoing epidemic and the key strategies to be adopted post pandemic for turning their businesses back to normal.
Regional Insights:
The Brachytherapy market is segmented as North America, South America, Europe, Asia Pacific, and Middle East and Africa. Researchers have thoroughly studied about the historical market. With extensive research, experts have offered details on the current and the forecast demand made by these regions. The Brachytherapy report also includes highlights on the prevailing product demanded by end users and end customers for better understanding of product demand by producers. This will help the producers and the marketing executives to plan their production quantity and plan effective marketing strategies to more buyers. Businesses can hence, increase their product portfolio and expand their global presence. Brachytherapy market research report further offers information on the unexplored areas in these regions to help the producers to plan promotional strategies and create demand for their new and updated products. This will again help the manufacturers to increase their customers and emerge as leaders in the near future.
Report Highlights | Details |
Market Size | US$ 106.2 Million by 2027 |
Growth Rate | CAGR of 9.20% From 2021 to 2027 |
Base Year | 2020 |
Historic Data | 2017 to 2020 |
No. of Pages | 250 |
Forecast Period | 2021 to 2027 |
Segments Covered | Product,Dosage Type,Application |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
Companies Mentioned | Varian Medical Systems, Inc.,Becton,Dickinson & Company,Elekta AB,Isoray Medical, Inc.,Eckert & Ziegler BEBIG,iCAD, Inc.,CIVCO Medical Solutions,Theragenics Corporation |
Major Players Covered in this Report
The updated market research report on Brachytherapy market allows the buyers and manufacturers to stay updated with the current market trends, ongoing happenings, and a clear picture on the market scenario. List of key players included in the research report will help the market vendors to know their market position and plan more operational strategies to gain topmost position among other players. The report offers crucial company information on each market player, such as company profile, financial information, and recently adopted growth strategies. This will help other existing players and the new entrants to plan strategies and establish their presence in the market.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Significant Market Participants Operational in the Brachytherapy Market are:
the brachytherapy market include:
Market Segmentation:
The report is divided into major categories comprising product, application, regions and others. Every segment is further sub-segmented into several sub-segmented that are deeply analyzed by experts to offer valuable information to the buyers and market players. Every segment is studied thoroughly in order to offer a better picture to the buyers and stakeholders to benefit from. Information like highest prevailing product, highly demanded product by the application segment and end users are rightly mentioned in the Brachytherapy report.
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Brachytherapy market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Brachytherapy market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
In this study, the years considered to estimate the market size of Brachytherapy are as follows:
The Queries answered by Brachytherapy Market Research Report include:
Research Methodology
In order to compile the research report, we conducted in-depth interviews and discussions with a number of key industry participants and opinion leaders. Primary research represents the bulk of research efforts, supplemented by extensive secondary research. We reviewed key players’ product literature, annual reports, press releases, and relevant documents for competitive analysis and market understanding. Secondary research also includes a search of recent trade, technical writing, internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise market data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that are typically referred to include, but are not limited to company websites, annual reports, financial reports, broker reports, investor presentations, and SEC filings, internal and external proprietary databases, and relevant patent and regulatory databases, national government documents, statistical databases, and market reports, news articles, press releases, and webcasts specific to companies operating in the market, National government documents, statistical databases, and market reports.
Primary research involves e-mail interactions, telephonic interviews, and face-to-face interviews for each market, category, segment, and sub-segment across geographies. We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate the data and analysis. Primary interviews provide firsthand information on market size, market trends, growth trends, competitive landscape, and outlook, etc. These help validate and strengthen secondary research findings. These also help develop the analysis team’s expertise and market understanding.
OBJECTIVES OF THE STUDY
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Brachytherapy Market, By Product
7.1. Brachytherapy Market, by Product, 2021-2027
7.1.1. Seeds
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Applicators & Afterloaders
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Applicators & Afterloaders
7.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Brachytherapy Market, By Dosage Type
8.1. Brachytherapy Market, by Dosage Type, 2021-2027
8.1.1. HDR Brachytherapy
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. HDR Brachytherapy
8.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Brachytherapy Market, By Application
9.1. Brachytherapy Market, by Application, 2021-2027
9.1.1. Prostate Cancer
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Prostate Cancer
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Breast Cancer
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 10.Global Brachytherapy Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2016-2027)
10.1.2. Market Revenue and Forecast, by Dosage Type (2016-2027)
10.1.3. Market Revenue and Forecast, by Application (2016-2027)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.1.4.2. Market Revenue and Forecast, by Dosage Type (2016-2027)
10.1.4.3. Market Revenue and Forecast, by Application (2016-2027)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.1.5.2. Market Revenue and Forecast, by Dosage Type (2016-2027)
10.1.5.3. Market Revenue and Forecast, by Application (2016-2027)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.2. Market Revenue and Forecast, by Dosage Type (2016-2027)
10.2.3. Market Revenue and Forecast, by Application (2016-2027)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.4.2. Market Revenue and Forecast, by Dosage Type (2016-2027)
10.2.4.3. Market Revenue and Forecast, by Application (2016-2027)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.5.2. Market Revenue and Forecast, by Dosage Type (2016-2027)
10.2.5.3. Market Revenue and Forecast, by Application (2016-2027)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.6.2. Market Revenue and Forecast, by Dosage Type (2016-2027)
10.2.6.3. Market Revenue and Forecast, by Application (2016-2027)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.7.2. Market Revenue and Forecast, by Dosage Type (2016-2027)
10.2.7.3. Market Revenue and Forecast, by Application (2016-2027)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.2. Market Revenue and Forecast, by Dosage Type (2016-2027)
10.3.3. Market Revenue and Forecast, by Application (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.4.2. Market Revenue and Forecast, by Dosage Type (2016-2027)
10.3.4.3. Market Revenue and Forecast, by Application (2016-2027)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.5.2. Market Revenue and Forecast, by Dosage Type (2016-2027)
10.3.5.3. Market Revenue and Forecast, by Application (2016-2027)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.6.2. Market Revenue and Forecast, by Dosage Type (2016-2027)
10.3.6.3. Market Revenue and Forecast, by Application (2016-2027)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.7.2. Market Revenue and Forecast, by Dosage Type (2016-2027)
10.3.7.3. Market Revenue and Forecast, by Application (2016-2027)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.2. Market Revenue and Forecast, by Dosage Type (2016-2027)
10.4.3. Market Revenue and Forecast, by Application (2016-2027)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.4.2. Market Revenue and Forecast, by Dosage Type (2016-2027)
10.4.4.3. Market Revenue and Forecast, by Application (2016-2027)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.5.2. Market Revenue and Forecast, by Dosage Type (2016-2027)
10.4.5.3. Market Revenue and Forecast, by Application (2016-2027)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.6.2. Market Revenue and Forecast, by Dosage Type (2016-2027)
10.4.6.3. Market Revenue and Forecast, by Application (2016-2027)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.7.2. Market Revenue and Forecast, by Dosage Type (2016-2027)
10.4.7.3. Market Revenue and Forecast, by Application (2016-2027)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.5.2. Market Revenue and Forecast, by Dosage Type (2016-2027)
10.5.3. Market Revenue and Forecast, by Application (2016-2027)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.5.4.2. Market Revenue and Forecast, by Dosage Type (2016-2027)
10.5.4.3. Market Revenue and Forecast, by Application (2016-2027)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.5.5.2. Market Revenue and Forecast, by Dosage Type (2016-2027)
10.5.5.3. Market Revenue and Forecast, by Application (2016-2027)
Chapter 11. Company Profiles
11.1. Varian Medical Systems, Inc
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Becton,Dickinson & Company
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Elekta AB
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Isoray Medical, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Eckert & Ziegler BEBIG,iCAD, Inc
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. CIVCO Medical Solutions
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Theragenics Corporation
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms